Unilever (UL) (ARRS) (EL) (CRL) (S) (CVD) Upgraded

Unilever (NYSE: UL), Arris Group, Inc. (NASDAQ: ARRS), Estee Lauder Companies Inc (NYSE: EL), Charles River Laboratories (NYSE: CRL), Sprint Nextel (NYSE: S) and Covance Inc. (NYSE: CVD) upgraded by analysts.

Unilever (UL) was upgraded by BNP Paribas from an “Underperform” rating to an “Outperform” rating.

Arris Group, Inc. (ARRS) was upgraded by Avondale Partners from a “Market Perform” rating to an “Outperform” rating. They have a price target of $14.00 on the company, up from $12.00.

Estee Lauder Companies Inc. (EL) was upgraded by BMO Capital Markets from a “Market Perform” rating to an “Outperform” rating. They have a price target of $115.00 on the company, up from $95.00.

Charles River Laboratories (CRL) was upgraded by Lazard Capital from a “Sell” rating to a “Neutral” rating.

Sprint Nextel (S) was upgraded by Collins Stewart from a “Neutral” rating to a “Buy” rating. They have a price target of $5.00 on the company.

Covance Inc. (CVD) was upgraded by Lazard Capital from a “Neutral” rating to a “Buy” rating.

Coverage on (CRL) (MTZ) (PWR) (PFE) (MRK) Initiated by Analysts

Charles River Laboratories International Inc. (NYSE:CRL), Mastec Inc. (NYSE:MTZ), Quanta Services Inc. (NYSE:PWR), Pfizer Inc. (NYSE:PFE) and Merck (NYSE:MRK) had coverage initiated on them by analysts.

Deutsche Bank (NYSE:DB) initiated coverage on Charles River Laboratories International Inc. (CRL), starting them off with a "Hold" rating. They lowered their price target from $44 to $41.50 on the company.

FBR Capital Markets initiated coverage on Mastec Inc. (MTZ), starting them off with an "Outperform" rating.

FBR Capital Markets initiated coverage on Quanta Services Inc. (PWR), starting them off with an "Underperform" rating. They lowered their price target from $20 to $19 on the company.

Credit Suisse (NYSE:CS) initiated coverage on Pfizer Inc. (PFE), starting them off with an "Outperform" rating. They placed a price target of $23 on the company.

Credit Suisse initiated coverage on Merck (NYSE:MRK), starting them off with an "Outperform" rating. They placed a price target of $44 on the company.

Price Targets on (BMC) (CMCSA) (CRL) (CSX) (DLR) Updated by Analysts

Price targets on BMC Software, Inc. (NYSE: BMC), Comcast Co. (NASDAQ: CMCSA), Charles River Laboratories (NYSE: CRL), CSX Corp. (NYSE: CSX) and Digital Realty Trust, Inc. (NYSE: DLR) were updated by analysts.

Credit Suisse (NYSE:CS) raised their price target on BMC Software, Inc. (BMC) from $55.00 to $62.50. They have an “outperform” rating on the company.

Kaufman Brothers raised their price target on Comcast Co. (CMCSA) from $28.00 to $30.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Charles River Laboratories (CRL) from $40.00 to $42.00. They have a “neutral” rating on the company.

Longbow Research raised their price target on CSX Corp. (CSX) from $90.00 to $92.00. They have a “buy” rating on the company.

UBS AG raised their price target on Digital Realty Trust, Inc. (DLR) from $45.00 to $49.00. They have a “sell” rating on the company.